2nd Quarter - Report

INVARIANT LLC for CIGNA CORPORATION

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Pharmacy issues related to H.R 6395 / S. 4049, the National Defense Authorization Act for Fiscal Year 2021.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
LINDLEY SHERER —
KATHRYN WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6395 (116th), S. 4049 (116th)

Health Issues HCR

Monitor issues related to telehealth during the COVID-19 emergency; issues related to H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act); issues related to H.R. 6810, the Health Care Protection Act, H.R. 6379, the Take Responsibility for Workers and Families Act, and H.R. 6514, the Worker Health Coverage Protection Act; issues related to H.R. 861, the End Surprise Billing Act; H.R. 3502, The Protecting People from Surprise Medical Bills Act; H.R.2328, Community Health Investment, Modernization, and Excellence Act of 2019 and H.R. 3630, The No Surprises Act, and H.R. 5800, The Ban Surprise Billing Act; issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). HR 6379, Take Responsibility for Workers and Families Act; issues related to S. 1895, the Lower Health Care Costs Act, including: surprise billing, and transparency and information sharing in the individual and commercial markets; issues related to the drug and medical device supply chain concerns related to the coronavirus response efforts.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
KATHRYN WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5800 (116th), S. 1895 (116th), H.R. 2328 (116th), H.R. 861 (116th), H.R. 6379 (116th), H.R. 6514 (116th), H.R. 6810 (116th), H.R. 3630 (116th), H.R. 3502 (116th), H.R. 6800 (116th)

Medicare/Medicaid MMM

Pharmacy Direct and Indirect Remuneration (DIR) H.R. 1034, the Phair Pricing Act of 2019; S.640, the Phair Pricing Act of 2019; H.R. 803, the Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 1035, the Improving Transparency and Accuracy in Medicare Part D Spending Act.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
KATHRYN WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1035 (116th), H.R. 1034 (116th), H.R. 803 (116th), S. 640 (116th)

Pharmacy PHA

Issues related to drug shortages, and pharmaceutical procurement processes; pharmacy issues related to S. 1895, the Lower Health Care Costs Act.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
KATHRYN WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1895 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.